ArticleMolecular cancer therapeutics2018

Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.